LY2603618
Product Specifications
Background
LY2603618 is a potent (IC50 = 7nM) and selective (>1000x over Chk2) Checkpoint kinase 1 (Chk1) inhibitor.1 Chk1 is an important regulator of the DNA damage response – combination treatment of LY2603618 with other chemotherapeutic agents significantly increased tumor growth inhibition when compared to chemotherapeutic alone.2,3,4 LY2603618 caused a dramatic suppression of cell growth in MCF-7 and MDA-MB-231 human breast cancer cells via Chk1 inhibition induced upregulation of replication stress caused by oncogenes.5
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C
Product Datasheet
https://www.biossantibodies.com/datasheets/bs-82803C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2165469-01 0.1 mL
APC-Linked Monoclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
Ask
View Details 
MBS2165469-02 0.2 mL
APC-Linked Monoclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
Ask
View Details 
MBS2165469-03 0.5 mL
APC-Linked Monoclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
Ask
View Details MBS2165469-04 1 mL
APC-Linked Monoclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
Ask
View Details 
MBS2165469-05 5 mL
APC-Linked Monoclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
Ask
View Details MBS2165469-06 5x 5 mL
APC-Linked Monoclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
Ask
View Details